Genovis gets new funding
Vinnova distributes SEK 66 million to 59 projects in SMEs (small and medium-sized enterprises) around the country. Among these recipients is an Ideon company, Genovis, which has been awarded SEK 1.75 million for its project on nanoparticles in movement and their function as a contrast agent in medical ultrasound.
Cooperating with Genovis on the project is reader Thomas Jansson’s research team from the Department of Measurement Technology and Industrial Electrical Engineering at LTH.
The project has so far resulted in a contrast agent and a method which is unique to ultrasound. The method is based on the use of a variable magnetic field which causes magnetic nanoparticles to move in tissue. Their movement can then be detected using ultrasound to reveal the location of tumours, for example.
The CEO of Genovis, Sarah Fredriksson, PhD in Engineering from LTH, now hopes to bring this method closer to a commercial application.